Telescope Innovations Corp. (TELI.CN)

CAD 0.29

(-9.38%)

Total Liabilities Summary of Telescope Innovations Corp.

  • Telescope Innovations Corp.'s latest annual total liabilities in 2022 was 1.35 Million CAD , up 446.82% from previous year.
  • Telescope Innovations Corp.'s latest quarterly total liabilities in 2023 Q2 was 864.65 Thousand CAD , down -7.17% from previous quarter.
  • Telescope Innovations Corp. reported annual total liabilities of 247.06 Thousand CAD in 2021, up 126.69% from previous year.
  • Telescope Innovations Corp. reported annual total liabilities of 108.98 Thousand CAD in 2020, down 0.0% from previous year.
  • Telescope Innovations Corp. reported quarterly total liabilities of 864.65 Thousand CAD for 2023 Q2, down -7.17% from previous quarter.
  • Telescope Innovations Corp. reported quarterly total liabilities of 328.49 Thousand CAD for 2023 Q3, down -62.01% from previous quarter.

Annual Total Liabilities Chart of Telescope Innovations Corp. (2022 - 2019)

Historical Annual Total Liabilities of Telescope Innovations Corp. (2022 - 2019)

Year Total Liabilities Total Liabilities Growth
2022 1.35 Million CAD 446.82%
2021 247.06 Thousand CAD 126.69%
2020 108.98 Thousand CAD 0.0%
2019 108.98 Thousand CAD 0.0%

Peer Total Liabilities Comparison of Telescope Innovations Corp.

Name Total Liabilities Total Liabilities Difference
Algernon Pharmaceuticals Inc. 2.71 Million CAD 50.326%
Asep Medical Holdings Inc 3.05 Million CAD 55.731%
BetterLife Pharma Inc. 8.02 Million CAD 83.155%
BioVaxys Technology Corp. 3.48 Million CAD 61.239%
ChitogenX Inc. 6.71 Million CAD 79.871%
Rapid Dose Therapeutics Corp. 5.04 Million CAD 73.21%
Defence Therapeutics Inc. 4.06 Million CAD 66.74%
Entheon Biomedical Corp. 85.32 Thousand CAD -1483.371%
Gemina Laboratories Ltd. 3.04 Million CAD 55.58%
Glow Lifetech Corp. 2.34 Million CAD 42.415%
Lexston Life Sciences Corp. 39.86 Thousand CAD -3288.665%
Pharmala Biotech Holdings Inc. 1.02 Million CAD -31.292%
Doseology Sciences Inc. 82.49 Thousand CAD -1537.767%
MYND Life Sciences Inc. 5.77 Million CAD 76.604%
Nova Mentis Life Science Corp. 841.66 Thousand CAD -60.519%
PharmaTher Holdings Ltd. 252.9 Thousand CAD -434.212%
PreveCeutical Medical Inc. 5.95 Million CAD 77.331%